Skip to main content
Nevada Public Radio
  • News 88.9 KNPR
  • Classical 89.7 kcnv
  • Magazine Desert Companion
  • About

    How to reach us

    1289 S. Torrey Pines Dr.
    Las Vegas, NV 89146

    Main Number:  1-702-258-9895
    Toll Free: 1-888-258-9895

    More contact info

     

     

      • Staff
      • Board of Directors
      • Employment
      • CPB Compliance
      • Our Policies
      • Our Business Members
      • Listen on the Radio
      • Other Ways to Listen
      • Sign-up for NVPR News
      • FCC Public Inspection File
      • CPB Funding
      • History
    • News 88.9 KNPR
    • Classical 89.7 KCNV
    • Desert Companion
  • Programs

    On News 88.9 KNPR

    On Classical 89.7

    News

    • All Things Considered
    • BBC World Service
    • Here & Now
    • Hidden Brain
    • It's Been a Minute with Sam Sanders
    • KNPR's State of Nevada
    • Marketplace
    • Morning Edition
    • On the Media
    • Planet Money - How I Built This
    • Reveal
    • Take Two
    • The Daily
    • The Takeaway
    • Weekend Edition Saturday
    • Weekend Edition Sunday

    Humor

    • Ask Me Another
    • Live Wire!
    • Wait Wait...Don't Tell Me!

    Arts & Life

    • Bullseye
    • Desert Bloom
    • Fresh Air
    • Nevada Yesterdays
    • Radiolab
    • Snap Judgment
    • Sound Opinions
    • TED Radio Hour
    • The Business
    • The Moth
    • This American Life

    Classical

    • Chicago Symphony Orchestra
    • Classical Music
    • Concierto
    • From the Top
    • Music from the Hearts of Space
    • New York Philharmonic
    • Performance Today
    • Pipedreams
    • Pittsburgh Symphony Orchestra
    • Sunday Baroque
    • SymphonyCast

    Special Projects

    • Race and Racism in Nevada
    • StoryCorps Virtual: Las Vegas
    • Coronavirus - What You Need to Know
    • Fifth Street
  • Projects
  • Support
      • Support NVPR
      • Contact Member Services
      • Corporate Support
      • Donate your Car
      • Give Voice Major Gift Initiative
      • myPublicRadio
      • NVPR Facebook Fundraisers FAQ
      • Planned Giving
      • Volunteer
    • myPublicRadio
    • Donate Now
        • Member Benefits

    Main menu

    Search

    Listen

    News 88.9 KNPR
    Classical 89.7 KCNV
    Podcasts view all

    member station

    Support
    Subscribe to pfizer

    pfizer

    NPR
    Coronavirus Updates
    The U.S. government has reached a deal with Pfizer to purchase 100 million more doses of the vaccine developed jointly with BioNTech.
    Tweet Share on Facebook Share on Google+ Email

    U.S. Reaches Deal With Pfizer For 100 Million More Vaccine Doses

    Dec 23, 2020

    The new deal effectively doubles the federal government's order from the company. Pfizer says the U.S. government has agreed to pay $1.95 billion for the additional doses.

    NPR
    Coronavirus Updates
    U.S. Army General Gustave Perna told reporters Saturday that some 7.9 million doses of COVID-19 vaccines are ready for distribution next week.
    Tweet Share on Facebook Share on Google+ Email

    Warp Speed Official: 7.9 Million Doses Of Vaccine Ready For Distribution Next Week

    Dec 19, 2020
    The top military official with the federal vaccine effort spoke less than 24 hours after Moderna's COVID-19 vaccine became the second to receive an emergency use authorization from the FDA.
    NPR
    Coronavirus Updates
    An example of a vial that will carry the COVID-19 vaccine produced by Pfizer and BioNTech sits on display during a Senate subcommittee hearing Thursday.
    Tweet Share on Facebook Share on Google+ Email

    FDA Authorizes COVID-19 Vaccine For Emergency Use In U.S.

    Dec 11, 2020
    Pfizer and BioNTech's vaccine is the first to receive an emergency authorization from the Food and Drug Administration. Officials say it may be ready for widespread inoculations within days.
    NPR
    National
    Food and Drug Administration building is shown Thursday, in Silver Spring, Md. A U.S. government advisory panel convened to decide whether to endorse emergency use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000
    Tweet Share on Facebook Share on Google+ Email

    Transporting And Distributing Vaccines Will Be 'Unprecedented' Logistical Operation

    Dec 11, 2020
    As FDA emergency use authorization of Pfizer and Moderna vaccines nears, airlines, FedEx and UPS prepare to transport millions of vials of life saving shots.
    • Listen Download
    NPR
    National
    Dry ice will be used to help keep the Pfizer vaccine at ultracold temperatures.
    Tweet Share on Facebook Share on Google+ Email

    At Hospitals, A Race To Save 'Hundreds Of Thousands' Of Lives With New Vaccine

    Dec 09, 2020
    With the first COVID-19 vaccine doses expected to be shipped out within days, health care providers are scrambling to prepare for an unprecedentedly high-stakes vaccine rollout.
    • Listen Download
    NPR
    Coronavirus Updates
    A nurse in the U.K. prepares to administer COVID-19 vaccinations this week. Canadian health officials on Wednesday authorized the use of the Pfizer-BioNTech vaccine.
    Tweet Share on Facebook Share on Google+ Email

    Canada Authorizes Use Of Pfizer COVID-19 Vaccine

    Dec 09, 2020
    The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.
    KNPR
    KNPR's State of Nevada
    Tweet Share on Facebook Share on Google+ Email

    Immunologist On COVID-19 Vaccine Technology

    Dec 08, 2020

    A vaccine for COVID-19 is on everyone’s minds right now. It’s seen as a possible light at the end of what has been a dark tunnel of a year.  

    • Listen Download
    NPR
    The Coronavirus Crisis
    A woman wears a mask as she walks by Pfizer's world headquarters in New York last month.
    Tweet Share on Facebook Share on Google+ Email

    EU Could Approve Pfizer, BioNTech COVID-19 Vaccine In December

    Dec 01, 2020
    If approved, the vaccine could be distributed before the end of the year, BioNTech says.
    NPR
    Medical Treatments
    The pharmaceutical giant Pfizer is formally requesting federal approval for emergency use of the company's COVID-19 vaccine
    Tweet Share on Facebook Share on Google+ Email

    Pfizer Asks FDA To Approve Its COVID-19 Vaccine For Emergency Use

    Nov 20, 2020

    The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.

    NPR
    Coronavirus Updates
    Pfizer CEO Albert Bourla says he expects the company will produce enough of its COVID-19 vaccine to reach 25 million people by the end of the year.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade

    Nov 20, 2020
    Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.
    • Listen Download
    NPR
    Shots - Health News
    Pfizer plans to file within days with the Food and Drug Administration to allow emergency use of its COVID-19 vaccine.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer To Seek FDA OK For COVID-19 Vaccine 'Within Days'

    Nov 18, 2020
    The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
    • Listen Download
    NPR
    Shots - Health News
    The Pfizer COVID-19 vaccine needs to be stored at minus 70 Celsius. Health care providers will need to store it either in dry ice for shorter stints or in specialized freezers.
    Tweet Share on Facebook Share on Google+ Email

    Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?

    Nov 17, 2020
    One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.
    • Listen Download
    NPR
    Investigations
    Albert Bourla, chairman and CEO of Pfizer, sold millions of dollars' worth of company stock on Monday as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions

    Nov 11, 2020
    Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
    • Listen Download
    NPR
    Coronavirus Live Updates
    The first patient enrolled in Pfizer's COVID-19 vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receives an injection in May.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer COVID-19 Vaccine Won't Be Ready By Election Day

    Oct 16, 2020
    Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.
    NPR
    Coronavirus Live Updates
    The agreement also would allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.
    Tweet Share on Facebook Share on Google+ Email

    U.S. To Get 100 Million Doses of Pfizer Coronavirus Vaccine In $1.95 Billion Deal

    Jul 22, 2020
    If the company's vaccine candidate pans out, Americans can receive it for free under the deal. The arrangement is part of the U.S. government's push to have a vaccine widely available by January.
    NPR
    The Two-Way
    Pfizer said it would be abandoning its neuroscience development programs and allocating its spending elsewhere.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer Halts Research Into Alzheimer's And Parkinson's Treatments

    Jan 08, 2018
    The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will lay off some 300 employees.
    KNPR
    Newscast headlines

    Nevada Won’t Return Execution Drug To Pfizer

    Nov 20, 2017

     

    LINCOLN, Neb.

    Tweet Share on Facebook Share on Google+ Email
    NPR
    The Two-Way
    This combination of undated photos provided by the Arkansas Department of Correction shows the death row inmates in question. Top row (from left): Jack Harold Jones Jr., Marcel Williams, Stacey E. Johnson, Ledell Lee. Bottom row (from left): Jason F. McG
    Tweet Share on Facebook Share on Google+ Email

    Courts Block 7 Executions Set For 11-Day Span In Arkansas

    Apr 14, 2017
    A county judge and the state supreme court ordered the state not to put the inmates to death. The larger case challenges lethal drugs. The other argues that the inmate is not sane.
    NPR
    Shots - Health News
    Syphilis can be wiped out with one to three shots of penicillin.
    Tweet Share on Facebook Share on Google+ Email

    Penicillin Shortage Could Be A Problem For People With Syphilis

    May 23, 2016
    The medication is the only one available to prevent an infected pregnant woman from passing the disease to a fetus. Pfizer says the shortage should be over in July.
    • Listen Download
    NPR
    The Two-Way
    Pfizer's corporate headquarters in midtown Manhattan.
    Tweet Share on Facebook Share on Google+ Email

    Pfizer To Stop Selling Drugs For Use In Lethal Injections

    May 13, 2016
    The drugmaker was the "last remaining open-market source of drugs used in executions," The New York Times reported. Other U.S. and European firms had already blocked drugs from use in executions.
    NPR
    The Two-Way
    A box of Lumigan eye-drops, produced by Allergan Plc, stands next to a box of Viagra tablets, produced by Pfizer Inc. The Irish and American drugmakers were planning to merge, but the deal has been called off after a change in U.S. tax law reduced the po
    Tweet Share on Facebook Share on Google+ Email

    Pfizer, Allergan Call Off Their $150 Billion Merger

    Apr 06, 2016
    Pfizer announced that the planned merger between the two pharmaceutical companies has been terminated because of a recent change in U.S. tax rules.
    NPR
    The Two-Way
    Pfizer is now based in New York City, but the drug giant's domicile would be moved to Ireland under the terms of its proposed merger with Allergan.
    Tweet Share on Facebook Share on Google+ Email

    New Rules On Inversions Could Kill The Allergan-Pfizer Merger

    Apr 05, 2016
    President Obama calls the controversial practice "one of the most insidious tax loopholes out there." Now the Treasury Department has introduced rules aimed at reducing the incentives for inversions.
    NPR
    The Two-Way
    The Pfizer flag flies in front of its world headquarters in New York. Pfizer and Dublin-based Allergan will merge, creating the world's biggest drug-maker by sales.
    Tweet Share on Facebook Share on Google+ Email

    Drug Giant Pfizer To Merge With Allergan In Deal To Lower Corporate Taxes

    Nov 23, 2015
    The deal will create the world's largest pharmaceutical company by sales, bringing together the makers of Viagra and Botox.
    • home
    • How to reach us
    • About
    • Support
    • Twitter
    • Facebook
    • NVPR News
    • Instagram

    © All Rights Reserved. | Privacy Policy

    PRXNPRAPMBBC INN